Clinical Trials Browser

OTHER × Cholangiocarcinoma × envafolimab × Clear all

NCT06643208 2025-06-26

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Gastrointestinal

Cholangiocarcinoma